Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 301 AL 315

The aging epigenome: integrative analyses reveal intersection with Alzheimer's disease

Zhang W, Lukacsovich D, Young JI, Gomez L, Schmidt MA, Kunkle BW, Chen X, Martin ER, Wang L; Alzheimer’s Disease Neuroimaging Initiative.

Geroscience. 2026 Jun;48(3):3185-3203. doi: 10.1007/s11357-026-02195-x. Epub 2026 Apr 14.

Path Integration in Alzheimer's Disease: Orientation, Movement, and Theta Rhythmicity

Castegnaro A, Kim M, Rudzka K, Burgess N.

Annu Rev Neurosci. 2026 Jul;49(1):451-470. doi: 10.1146/annurev-neuro-102124-020226. Epub 2026 Apr 16.

The effects of GLP-1 receptor agonists on Alzheimer's pathophysiology: A systematic review

Corcoran E, Kettlety M, Mogul U, Azah JN, Cork SC.

Mol Cell Neurosci. 2026 Jun;137:104091. doi: 10.1016/j.mcn.2026.104091. Epub 2026 Apr 20.

Progress and challenges in drug delivery for the treatment of Alzheimer's disease

Haghighi FH, Xie J, Ebert ET, Siahaan TJ.

Expert Opin Drug Deliv. 2026 Jul;23(7):1305-1327. doi: 10.1080/17425247.2026.2663114. Epub 2026 Apr 28.

How amyloid-β peptide choice shapes neurochemical outcomes in intracerebral rat models of Alzheimer's disease: A systematic review

Agavriloaei LM, Costachescu I, Szilagyi A, Gogu MR, Iliescu BF, Turliuc MD.

J Alzheimers Dis. 2026 Jun;111(4):1483-1498. doi: 10.1177/13872877261443555. Epub 2026 Apr 23.

Mitochondrial-nuclear crosstalk: A central axis in Alzheimer's disease

Samantaray K, Sinha A, Tomar D, Jadiya P.

Ageing Res Rev. 2026 Jul;119:103150. doi: 10.1016/j.arr.2026.103150. Epub 2026 Apr 25.

Serious side effects of Alzheimer's immunotherapy demand scrutiny

Høilund-Carlsen PF, Alavi A, Andalib S, Castellani RJ, Costa T, de Girolamo G, Espay AJ, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B, Barrio JR.

Ageing Res Rev. 2026 Jul;119:103151. doi: 10.1016/j.arr.2026.103151. Epub 2026 Apr 27.

Tiny Titans, big promise: Nanotechnology and microRNA in the fight against Alzheimer's disease

Nakum B, Vejpara D, Faldu K, Soni R, Shah J.

Ageing Res Rev. 2026 Jul;119:103149. doi: 10.1016/j.arr.2026.103149. Epub 2026 Apr 27.

Apolipoprotein E4 and synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic implications

Yao Z, Godje ISG, Jiao B, Shen L, Luo S.

Ageing Res Rev. 2026 Jul;119:103153. doi: 10.1016/j.arr.2026.103153. Epub 2026 Apr 28.

Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation

Sopko Z, Pačesová A, Železná B, Maletínská L.

Biosci Rep. 2026 Jul 22;46(7):BSR20250362. doi: 10.1042/BSR20250362.

Probiotics combat sarcopenia by restoring gut integrity in Alzheimer's disease

Qaisar R, Iqbal MS, Ahmad F, Karim A.

Explore (NY). 2026 Jul-Aug;22(4):103428. doi: 10.1016/j.explore.2026.103428. Epub 2026 Apr 24.

Choroid plexus volume in Alzheimer's disease: A systematic review and meta-analysis

Mahmoudi F, Yazdan Panah M, Dehghani Firouzabadi D, Vaheb S, Ghoshouni H, Flores Gonzalez R, Shaygannejad V, Mirmosayyeb O.

J Alzheimers Dis. 2026 Jul;112(1):53-64. doi: 10.1177/13872877261447404. Epub 2026 May 4.

RNA-based therapeutics for Alzheimer's disease and related tauopathies: challenges and opportunities

Rajbanshi B, Brentari I, Denti MA, Cummings JL, Guruacharya A.

J Prev Alzheimers Dis. 2026 Aug;13(7):100585. doi: 10.1016/j.tjpad.2026.100585. Epub 2026 May 7.

Asymptomatic Versus Symptomatic Alzheimer's Disease Neuropathology: A Systematic Review of Differences Reported in Post-Mortem Studies

Barros TGR, Grossi LB, da Silva Campos ML, Cardoso IBN, Teixeira AL, de Miranda AS, de Brito Toscano EC.

Neuropathol Appl Neurobiol. 2026 Jun;52(3):e70077. doi: 10.1111/nan.70077.

Urolithin A: Potential to enhance autophagic clearance and mitigate neuroinflammation in Alzheimer's disease

Xiang J, Xu J, Zhang Y, Liu X.

Ageing Res Rev. 2026 Jul;119:103157. doi: 10.1016/j.arr.2026.103157. Epub 2026 May 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias